Hints and tips:
Showing results for Janssen Pharmaceutica Inc. doing business as Janssen Pharmaceuticals Inc.
Related Special Reports
...Janssen is the pharmaceutical division of J&J....
...What that shows is that big companies have shied away from doing mega deals but smaller acquisitions have gone ahead as they probably posed less of a threat....
...For the GSK legal team, this meant recasting itself to support a smaller, more focused pharmaceutical business....
...“It is not at all clear that Merck is doing anything other than extending its monopoly power over the drug,” Warren said....
...But they warn that the ruling casts a shadow over the company as it seeks to remodel itself as an innovator in the pharmaceutical and medical devices sectors....
...“People were thinking that I’m trying to go into the pharma business [as] window dressing for my tobacco business,” he says. He is accustomed to receiving a frosty reception from scientists....
...As the rollout of bivalent boosters for Covid-19 continues, experts are concerned that the US isn’t doing enough to support the development of the next wave of vaccines and treatments that the world needs...
...Visa and Mastercard play an important role in policing highly regulated, high-risk commerce such as gambling or pharmaceuticals, or other sectors prone to fraud....
...Not only was the BioNTech/Pfizer vaccine the first to be deployed but it has suffered less from rare side effects and manufacturing glitches than its big western rivals Oxford/AstraZeneca, Janssen or Moderna...
...The chief executives of Pfizer, BioNTech and Moderna have shared more than $100mn in pay during the pandemic reflecting the huge commercial success of the mRNA Covid vaccines developed by their pharmaceutical...
...“Significant increases” in antibody responses were seen in people aged 18 to 55, as well as those older than 65, who were given a lower dose....
...“If everybody started doing what the European Commission is doing, you know if China thought, hey, we can assert jurisdiction between the merger of any two companies anywhere in the world . . . then as a...
...Paul Stoffels, chief scientific officer, said J&J was working with “great urgency” to make the vaccine available “as quickly as possible”....
...Regeneron, though, is hardly a mom-and-pop business. It has a market value of $60bn....
...for its combined pharmaceuticals and medical device business....
...“We are doing everything we can to vaccinate all adults as quickly as possible and I encourage everybody to come forward for a jab as soon as they are eligible.”The UK is racing to vaccinate as many people...
...“This is a 2025 product — so they [Merck] can give investors some confidence about the growth rate of the business....
...The fact that it is now known universally as the Pfizer shot is “the biggest marketing coup in the history of American pharmaceuticals”....
..., J&J’s pharmaceutical division, told the panel on Friday: “Janssen’s vaccine candidate would play a critical role in the global efforts to fight Covid-19 . . ....
...We know that they’re committed to doing this,” the official said....
...Investors are being asked to forgo about £60m to avoid doing business with a company whose main product kills people. That would be short-sighted and simplistic....
...The deal will give J&J’s drugmaking division Janssen Pharmaceutica access to Momenta’s pipeline of products, including nipocalimab, a promising treatment for the rare muscular disease myasthenia gravis that...
...Moderna and BioNTech shares jumped 10.5 per cent and 6.1 per cent, respectively, on Tuesday as the vaccine makers benefited from news of the J&J pause....
...J&J is preparing to test a new formulation that could be targeted at the 501.v2 variant, but Mathai Mammen, global head of research and development for Janssen, J&J’s pharmaceuticals division, said he was...
...Kate Bingham, head of the UK vaccine task force, said the trial was part of an effort to ensure there is access to safe and effective vaccines as soon as possible....
International Edition